Invention Grant
- Patent Title: Methods of use of soluble CD24 for treating lupus nephritis
-
Application No.: US16491708Application Date: 2018-03-06
-
Publication No.: US11571461B2Publication Date: 2023-02-07
- Inventor: Yang Liu , Pan Zheng , Martin Devenport
- Applicant: ONCOIMMUNE, INC.
- Applicant Address: US MD Rockville
- Assignee: ONCOIMMUNE, INC.
- Current Assignee: ONCOIMMUNE, INC.
- Current Assignee Address: US MD Rockville
- Agent Sylvia A. Ayler; Catherine D. Fitch
- International Application: PCT/US2018/021214 WO 20180306
- International Announcement: WO2018/165204 WO 20180913
- Main IPC: C07K14/47
- IPC: C07K14/47 ; C07K14/475 ; C07K14/705 ; C07K16/28 ; C07K19/00 ; A61K38/17 ; A61K38/18 ; A61K39/395 ; A61P37/06
Abstract:
The present invention relates to the use of a CD24 protein for treating Systemic Lupus Erythematosus (Lupus, SLE).
Public/Granted literature
- US20220125874A1 METHODS OF USE OF SOLUBLE CD24 FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS Public/Granted day:2022-04-28
Information query
